326 related articles for article (PubMed ID: 25950148)
1. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
3. There is no correlation between sublineages and drug resistance of Mycobacterium tuberculosis Beijing/W lineage clinical isolates in Xinjiang, China.
Yuan L; Huang Y; Mi LG; Li YX; Liu PZ; Zhang J; Liang HY; Li F; Li H; Zhang SQ; Li WJ
Epidemiol Infect; 2015 Jan; 143(1):141-9. PubMed ID: 24667051
[TBL] [Abstract][Full Text] [Related]
4. Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.
Zhang J; Mi L; Wang Y; Liu P; Liang H; Huang Y; Lv B; Yuan L
BMC Res Notes; 2012 Jun; 5():309. PubMed ID: 22713520
[TBL] [Abstract][Full Text] [Related]
5. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
[TBL] [Abstract][Full Text] [Related]
6. Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia.
Nieto Ramirez LM; Ferro BE; Diaz G; Anthony RM; de Beer J; van Soolingen D
PLoS One; 2020; 15(4):e0224908. PubMed ID: 32330146
[TBL] [Abstract][Full Text] [Related]
7. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
8. [Population structure analysis of Mycobacterium tuberculosis Beijing family in Japan].
Iwamoto T
Kekkaku; 2009 Dec; 84(12):755-9. PubMed ID: 20077859
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal dynamics of drug-resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high-priority country.
Mokrousov I; Vyazovaya A; Levina K; Gerasimova A; Zhuravlev V; Viiklepp P; Kütt M
Transbound Emerg Dis; 2021 Mar; 68(2):896-906. PubMed ID: 32737943
[TBL] [Abstract][Full Text] [Related]
12. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition.
Yao C; Guo H; Li Q; Zhang X; Shang Y; Li T; Wang Y; Xue Z; Wang L; Li L; Pang Y
Antimicrob Resist Infect Control; 2021 Aug; 10(1):126. PubMed ID: 34446095
[TBL] [Abstract][Full Text] [Related]
14. Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.
Daum LT; Konstantynovska OS; Solodiankin OS; Liashenko OO; Poteiko PI; Bolotin VI; Hrek II; Rohozhyn AV; Rodriguez JD; Fischer GW; Chambers JP; Gerilovych AP
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563202
[TBL] [Abstract][Full Text] [Related]
15. Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94-32 central Asian/Russian clusters.
Klotoe BJ; Kacimi S; Costa-Conceicão E; Gomes HM; Barcellos RB; Panaiotov S; Haj Slimene D; Sikhayeva N; Sengstake S; Schuitema AR; Akhalaia M; Alenova A; Zholdybayeva E; Tarlykov P; Anthony R; Refrégier G; Sola C
BMC Infect Dis; 2019 Jun; 19(1):553. PubMed ID: 31234780
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru.
Cáceres O; Rastogi N; Bartra C; Couvin D; Galarza M; Asencios L; Mendoza-Ticona A
PLoS One; 2014; 9(12):e112789. PubMed ID: 25489950
[TBL] [Abstract][Full Text] [Related]
17. Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation.
Mokrousov I; Vyazovaya A; Solovieva N; Sunchalina T; Markelov Y; Chernyaeva E; Melnikova N; Dogonadze M; Starkova D; Vasilieva N; Gerasimova A; Kononenko Y; Zhuravlev V; Narvskaya O
BMC Microbiol; 2015 Dec; 15():279. PubMed ID: 26679959
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity and drug resistance of Mycobacterium tuberculosis in Yunnan, China.
Li D; Song Y; Yang P; Li X; Zhang AM; Xia X
J Clin Lab Anal; 2019 Jun; 33(5):e22884. PubMed ID: 30896073
[TBL] [Abstract][Full Text] [Related]
19. [Study on the prevalence of Beijing genotype Mycobacterium tuberculosis and its relationship with second-line anti-tuberculosis drug resistance].
Liang C; Zhang XX; Xing Q; Yi JL; Zhang YQ; Li CY; Liu Y; Tang SJ
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):356-361. PubMed ID: 32294818
[No Abstract] [Full Text] [Related]
20. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
